m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
/MF-Logo-img/73700.png

WhiteOak Capital Pharma and Healthcare Fund-Dir (G)

Sectoral / Thematic
  • NAV

    14.56(-0.25%)
  • Fund Size (CR)

    ₹480.08
  • Expense Ratio

    0.65
  • Scheme Type

    Active Fund
  • Value Research

  • Min. investment

    ₹500
  • Minimum Additional Investment

    ₹500
  • Minimum SIP Investment

    ₹100
  • Minimum Withdrawal

    ₹500
  • Exit Load In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

    1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment

    1%
  • Return Since Launch

    23.29%
  • 3M
  • 6M
  • 1Y
  • 3Y
  • All
Absolute Return: 3.24%
Annualized Return: 0% [object Object]
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment

Basic Details

Scheme Manager

Ramesh Mantri

Bench Mark

BSE Healthcare TRI

Type

OPEN

Lumpsum Returns

Period Invested For₹10,000 Invested onLatest ValueAbsolute ReturnsAnnualised ReturnsCategory AvgRank within Category
1 Week 19 November 202510037.140.37%-0.07%271/936
1 Month24 October 202510027.480.27%-0.60%512/932
3 Month26 August 202510233.502.34%-4.01%645/916
6 Month26 May 202510978.719.79%-6.11%106/872
1 Year26 November 202411053.5510.54%10.54%5.60%156/766
3 Year------/-
5 Year------/-
Since Inception6 February 202414594.0045.94%23.29%13.64%74/940

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For₹10,000 Invested onInvestmentsLatest ValueAbsolute ReturnsAnnualised Returns
1 Year2 December 20241,20,000129103.007.59% 7.59%
3 Year-----
5 Year-----
10 Year-----

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

  • Investment type
  • Scheme based
  • SIP
  • Lumpsum

Monthly Investment (₹)

Minimum value allowed is 500

Expected Returns Rate (%)

Minimum value allowed is 1

Time Period (in Years)

Minimum value allowed is 1
  • Invested Amount

    25,000

  • Estimated Returns

    19,059

76%

Returns

Future value of your investment

44,059

Risk Ratios

4.87%

Standard Deviation

0.82%

Beta

1.01%

Sharpe Ratio

0.03%

Treynor's Ratio

13.98%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in% of Total HoldingsQuantityValue (Cr)Asset TypeSegment
Sun Pharma.Inds.7.82%22192337.52EquityPharmaceuticals
Divi's Lab.6.87%4891532.96EquityPharmaceuticals
J B Chemicals &6.48%18504731.13EquityPharmaceuticals
Fortis Health.6.32%29665630.35EquityHealthcare
Laurus Labs4.68%23555022.46EquityPharmaceuticals
Cipla4.20%13416120.14EquityPharmaceuticals
Neuland Labs.3.82%1114418.36EquityPharmaceuticals
Lupin3.73%9123917.91EquityPharmaceuticals
Sai Life2.94%15391314.13EquityPharmaceuticals
Krishna Institu.2.73%18162413.10EquityHealthcare

Peer Comparison

Scheme NameValue ResearchAsset Size (Cr)1M3M6M1Y3Y
WhiteOak Capital Pharma and Healthcare Fund-Dir (G)
480.080.27%2.34%9.79%10.54%-
Nippon India Taiwan Equity Fund - Direct (G)
421.514.87%14.71%50.13%49.53%37.20%
Nippon India Taiwan Equity Fund - Direct (IDCW)
421.514.87%14.71%50.13%49.53%37.20%
Aditya Birla SL International Equity Fund - Direct (G)
273.510.11%4.32%17.26%29.47%15.62%
Aditya Birla SL International Equity Fund - Direct (IDCW)
273.510.11%4.32%17.26%29.47%15.62%
Quant BFSI Fund - Direct (G)
680.732.05%10.17%18.84%25.09%-

List of Schemes under WhiteOak Capital Mutual Fund

News

  • WhiteOak Capital Mutual Fund Announces Resignation of Key Personnel

    WhiteOak Capital Mutual Fund has announced that, Mr. Vaiibhavv Chugh will cease to be the Head ' Sales of WhiteOak Capital Asset Management Limited w.e.f. the close of business hours of September 30, 2025.

    Powered by Capital Market - Live News

  • WhiteOak Capital Mutual Fund announces change in Key Personnel

    WhiteOak Capital Mutual Fund has announced that Mr. Siddhartha Chaturvedi has been appointed as a Chief Information Security Officer on the Board of the Trustee Company with effect from July 01, 2025.

    Details of Mr. Siddhartha Chaturvedi

    Age: 43

    Designation: Chief Information Security Officer

    Qualification : B.Tech. ' Information Technology, CISA, CEH, CND, CCNA (S & R), CCNA (Security), ITIL Foundation, RBI Certified Cyber Security Professional (Under AVTU) Mission, ISEA Certified Cyber Hygiene Practitioner from MeITY

    Experience: 16

    Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

16 January 2024

Total AUM (Cr)

₹480.08

WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹480.08 (Cr), as of 27 November 2025, WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 23.29% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is ₹14.56, as on 27 November 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 90.88% in Equity, 9.17% in Debt and -0.05% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.06% in Pharmaceuticals & Biotech, 26.17% in Healthcare Services, 11.91% in Debt, 1.91% in Industrial Products, 1.25% in Healthcare Equipment & Su